A pharmacological study of a new sulfonamide in glucose-6-phosphate dehydrogenase deficient subjects.
D001663:Bilirubin / Q000097:blood; D003596:Cytosine / Q000008:administration & dosage / Q000627:therapeutic use; D004906:Erythrocyte Count; D005978:Glutathione / Q000097:blood; D005953:Glycogen Storage Disease Type I / Q000188:drug therapy*; D006400:Hematocrit; D006454:Hemoglobins; D006801:Humans; D008706:Methemoglobin; D012156:Reticulocytes / Q000187:drug effects; D013444:Sulfisoxazole / Q000008:administration & dosage / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D014556:Urine / Q000032:analysis
D006454:Hemoglobins; D013449:Sulfonamides; D013444:Sulfisoxazole; D003596:Cytosine; D008706:Methemoglobin; D005978:Glutathione; D001663:Bilirubin